BPM
UTHR icon

Bowling Portfolio Management’s United Therapeutics UTHR Stock Holding History

Bowling Portfolio Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,599
Closed -$1.32M – 205
2022
Q2 		$1.32M Buy
+5,599
New +$1.14M 0.33% 106
2018
Q2 		– Sell
-27,691
Closed -$3.11M – 408
2018
Q1 		$3.11M Buy
+27,691
New +$3.52M 0.43% 73
2017
Q4 		– Sell
-26,117
Closed -$3.06M – 409
2017
Q3 		$3.06M Sell
26,117
-5,174
-17% -$661K 0.46% 66
2017
Q2 		$4.06M Buy
31,291
+4,460
+17% +$556K 0.6% 43
2017
Q1 		$3.63M Sell
26,831
-18,199
-40% -$2.76M 0.6% 64
2016
Q4 		$6.46M Sell
45,030
-8,684
-16% -$1.11M 0.96% 24
2016
Q3 		$6.34M Buy
53,714
+4,679
+10% +$562K 0.89% 35
2016
Q2 		$5.19M Buy
49,035
+11,115
+29% +$1.24M 0.85% 58
2016
Q1 		$4.22M Buy
+37,920
New +$4.8M 0.68% 60
2014
Q4 		– Sell
-1,819
Closed -$234K – 144
2014
Q3 		$234K Buy
+1,819
New +$188K 0.05% 105
2014
Q2 		– Sell
-52,297
Closed -$4.92M – 128
2014
Q1 		$4.92M Sell
52,297
-597
-1% -$61.1K 1.17% 40
2013
Q4 		$5.98M Sell
52,894
-8
-0% -$721 1.47% 18
2013
Q3 		$4.17M Sell
52,902
-14,598
-22% -$1.07M 1.16% 46
2013
Q2 		$4.44M Buy
+67,500
New +$4.35M 1.3% 27

Other funds holding UTHR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Bowling Portfolio Management's UTHR Position: Q3 2022 in Review

Bowling Portfolio Management sold out of United Therapeutics (UTHR) in Q3 2022, closing a stake of 5,599 shares — an estimated $1.32M sold.

Bowling Portfolio Management first reported a position in UTHR in Q2 2013 and held it in 14 quarters. The position peaked at $6.46M in Q4 2016. 461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

  • Bowling Portfolio Management reported no remaining United Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bowling Portfolio Management sold 5,599 United Therapeutics shares in Q3 2022, an estimated $1.32M.
  • Bowling Portfolio Management first reported a position in United Therapeutics in Q2 2013 and held it in 14 quarters.
  • Bowling Portfolio Management's United Therapeutics position peaked at $6.46M in Q4 2016.
  • 461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.